Rate of TP53 mutations in HPV-positive (HPV+) recurrent/metastatic head and neck cancer (RMHNC) patients.

被引：0
|
作者：
Thach, Dzung
Ahmad, Moin
Penta, Adrienne L.
Sulkowski, Gisela N.
Kallakury, Bhaskar
Chahine, Joeffrey J.
Niederhuber, John E.
Iyer, Ramaswamy K.
Deeken, John F.
机构：
[1] Inova Translat Med Inst, Falls Church, VA USA
[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[3] Inova Comprehens Canc & Res Inst, Mclean, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17094
引用
收藏
页数：1
相关论文
共 50 条
  • [21] mRNA Expression of TP53 Attenuates Survival of HPV plus Locally Advanced Head and Neck Cancer
    Aneja, S.
    Contessa, J. N.
    Husain, Z. A.
    Glazer, P. M.
    Hansen, J. E.
    Bindra, R. S.
    Yu, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E350 - E351
  • [22] The Next Chapter in Cancer Diagnostics: Advances in HPV-Positive Head and Neck Cancer
    Krsek, Antea
    Baticic, Lara
    Braut, Tamara
    Sotosek, Vlatka
    BIOMOLECULES, 2024, 14 (08)
  • [23] The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature
    Flach, Susanne
    Maniam, Pavithran
    Hey, Shi Ying
    Manickavasagam, Jaiganesh
    CLINICAL OTOLARYNGOLOGY, 2024, 49 (04) : 384 - 403
  • [24] Comparison of T cell response in the tumor milieu of patients with HPV+ and HPV- head and neck cancer
    Bastian, T.
    Lang, S.
    Kansy, B. A.
    HNO, 2020, 68 (02) : 80 - 86
  • [25] Classification of TP53 mutations and HPV predict survival in advanced larynx cancer
    Scheel, Adam
    Bellile, Emily
    McHugh, Jonathan B.
    Walline, Heather M.
    Prince, Mark E.
    Urba, Susan
    Wolf, Gregory T.
    Eisbruch, Avraham
    Worden, Francis
    Carey, Thomas E.
    Bradford, Carol
    LARYNGOSCOPE, 2016, 126 (09): : E292 - E299
  • [26] Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
    Wegge, Marilyn
    Dok, Ruveyda
    Nuyts, Sandra
    CANCERS, 2021, 13 (23)
  • [27] Latency of tobacco smoking for head and neck cancer among HPV-positive and HPV-negative individuals
    Madathil, Sreenath
    Rousseau, Marie-Claude
    Joseph, Lawrence
    Coutlee, Francois
    Schlecht, Nicolas F.
    Franco, Eduardo
    Nicolau, Belinda
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (01) : 56 - 64
  • [28] The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(-) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
    Moe, Svein Erik
    Erland, Fredrik A.
    Fromreide, Siren
    Lybak, Stein
    Brydoy, Marianne
    Dongre, Harsh N.
    Dhayalan, Sophia M.
    Costea, Daniela-Elena
    Vintermyr, Olav K.
    Aarstad, Hans Jorgen
    BIOMEDICINES, 2023, 11 (07)
  • [29] ASSESSING SURVIVAL RATE OF HPV-POSITIVE AND HPV-NEGATIVE CERVICAL CANCER PATIENTS
    Ibragimova, M. K.
    Tsyganov, M. M.
    Churuksaeva, O. N.
    Kolomiets, L. A.
    Litviakov, N. V.
    INFEKTSIYA I IMMUNITET, 2019, 9 (3-4): : 595 - 599
  • [30] Outcomes following ablative therapy of pulmonary oligometastases in patients with HPV-positive head and neck cancer
    Ly, Sophia
    Huang, Shao Hui
    Bratman, Scott
    Cho, B. C. John
    Hosni, Ali
    Hanh, Ezra
    Kim, John
    McPartlin, Andrew
    Ringash, Jolie
    O'Sullivan, Brian
    Tsai, C. Jillian
    Waldron, John
    Goldstein, David
    Garcia, Enrique Sanz
    Spreafico, Anna
    Su, Jie
    Tong, Li
    Weinreb, Ilan
    Perez-Ordonez, Bayardo
    Hope, Andrew
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S40 - S42
12345